Patents by Inventor Jean-Jacques Helwig

Jean-Jacques Helwig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of PTHrP antagonists for treating renal cell carcinoma
    Patent number: 7727526
    Abstract: The present invention concerns the use of a PTHrP antagonist for preparing a pharmaceutical composition for treating renal cell carcinoma (RCC) in a mammal and in particular in a human subject. Advantageously, the invention is of particular interest for inhibiting or reducing tumour growth and/or metastasis formation in kidney cancer and its metastatic developments, in particular in the lung and the liver.
    Type: Grant
    Filed: July 4, 2003
    Date of Patent: June 1, 2010
    Assignees: Universite Louis Pasteur, Institut National de la Sante et de la Recherche Medicale (INSERM), Hopitaux Universitaires de Strasbourg
    Inventors: Thierry Massfelder, Herve Lang, Eric Schordan, Jean-Jacques Helwig
  • Use of pthrp antagonists for treating renal cell carcinoma
    Publication number: 20060003916
    Abstract: The present invention concerns the use of a PTHrP antagonist for preparing a pharmaceutical composition for treating renal cell carcinoma (RCC) in a mammal and in particular in a human subject. Advantageously, the invention is of particular interest for inhibiting or reducing tumour growth and/or metastasis formation in kidney cancer and its metastatic developments, in particular in the lung and the liver.
    Type: Application
    Filed: July 4, 2003
    Publication date: January 5, 2006
    Inventors: Thierry Massfelder, Eric Schordan, Jean-Jacques Helwig